Institutions · Entity Annotation Prototype (beta)

3articles mentioning institutions

4institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Swissmedic ×

Swissmedic

This institution is selected. Its supporting articles are shown below.

Swissmedic3

Articles mentioning Swissmedic

3 articles · page 1 of 1

Trends in pivotal clinical trial design and biomarker use: a retrospective analysis of oncology drug approval in Switzerland from 2001 to 2020

bmjconc · abstract · 2025-07-25 · 2 matching annotations

88.8%

Swissmedic lung cancer Solid tumours Cancer treatment cancer

…abase and performed descriptive analyses.Results Over 20 years, Swissmedic approved 362 cancer-related indications, 40.6% as new active su…

Maraviroc for Stroke Recovery (MASTER): protocol for a phase 2 double-blind placebo-controlled randomised clinical trial

bmjopen · abstract · 2026-05-03 · 1 matching annotations

88.1%

Swissmedic Geneva Competent Ethics Committee stroke Maraviroc Swiss Agency for Therapeutic Products NCT07080567 standard rehabilitation therapy

…antonale d’Éthique, CEC; Reference Number: CCER 2024-02359) and Swissmedic (Swiss Agency for Therapeutic Products). Written informed conse…

Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a randomised, double-blind, placebo-controlled, non-inferiority, multicentre study in Switzerland

bmjopen · abstract · 2025-12-31 · 1 matching annotations

87.1%

Ethikkommission Bern Swissmedic Swiss hospitals Visual Analogue Scale chronic pain Swiss National Science Foundation paracetamol alcoholism acetaminophen

…d dissemination The study was approved by the Ethics Committee (Ethikkommission Bern, reference number 2021-01518) and the Swiss Agency for Therapeu…